Medicamen Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
MEDICAMEQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medicamen Biotech has informed the exchanges that the trading window for dealing in its shares will be closed starting October 1, 2025, in line with SEBI's insider trading rules. The window will remain shut until 48 hours after the company declares its unaudited financial results (both standalone and consolidated) for the quarter and half-year ended September 30, 2025. This applies to all directors, designated persons, and connected persons, who have been advised not to trade in the company's shares during this period. The board meeting date to approve the Q2 and H1 FY26 results will be announced separately in due course.
This is a routine compliance filing and does not affect shareholders directly. However, it signals that the company's Q2 and H1 FY26 financial results will be announced soon, which investors should watch for as it could move the stock once the results are declared and trading resumes.